Despite a bullish average brokerage recommendation of 1.50 (Strong Buy/Buy equivalent), the article advises caution. The Zacks Rank of #3 (Hold) reflects unchanged earnings consensus estimates, suggesting the stock should perform in line with the market. The article emphasizes that brokerage recommendations are often overly optimistic due to vested interests, making the neutral Zacks Rank a more reliable indicator than the positive ABR.
Also mentions DBD
Articles that tag DBD but are mainly about other companies.
None recently.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
